Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

213
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
213
Tumor Immunotherapy01:27

Tumor Immunotherapy

556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?

Expert opinion on pharmacotherapy·2026
Same author

Clinically Assessed Tooth Loss and Malnutrition Risk in U.S. Older Adults.

Journal of oral rehabilitation·2026
Same author

Self‑Reported Oral Health and Malnutrition Risk in Community-Dwelling Older U.S. Adults.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·2026
Same author

Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease.

Expert opinion on emerging drugs·2026
Same author

Oral Frailty as a Marker of Intrinsic Capacity Decline: A Narrative Review on a Multisystemic Ageing Perspective.

Journal of oral rehabilitation·2026
Same author

Periodontal Disease as a Marker of Malnutrition Risk in Community-Dwelling Older Adults.

Journal of the American Medical Directors Association·2026

相关实验视频

Updated: Jul 18, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.4K

基于的被动免疫疗法用于病变.

Francesco Panza1, Vincenzo Solfrizzi2, Antonio Daniele3

  • 1Unit of Research Methodology and Data Sciences for Population Health, National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, Castellana Grotte, Bari, Italy.

Handbook of clinical neurology
|August 24, 2023
PubMed
概括

开发用于治疗包括阿尔茨海默氏症 (AD) 在内的多病症的疾病修饰药物仍然具有挑战性. 目前的研究重点是针对tau的被动免疫疗法,在对初级和二级tau病变的临床试验中,有几种抗tau抗体.

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.超级顶级域名 - 塔乌轻度认知障碍 轻度认知障碍单克隆抗体是一种单克隆抗体.这是PSPSPSPSPSPS塔乌·塔乌 (Tau Tau) 是一个

更多相关视频

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.4K
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

6.0K

相关实验视频

Last Updated: Jul 18, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.4K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.4K
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

6.0K
  • 药理学 药理学是指药理学的学科.

    • 背景情况:

    • 病是一种复杂的神经疾病,其特征是异常的蛋白聚合.
    • 在开发用于治疗包括阿尔茨海默病 (AD) 在内的初级和二级病的有效修改疾病的治疗方法方面取得了有限的进展.
    • 现有的病症的症状治疗方法的疗效有限.

    结论:

    • 被动免疫疗法代表了治疗病的有希望的途径.
    • 目前正在进行的I/II期试验将为这些新型免疫治疗药物的疗效提供进一步证据.
    • 进一步的研究和临床开发对于推进病治疗至关重要.